Literature DB >> 25633672

Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up.

Ellis Niemantsverdriet1, Bart F E Feyen2, Nathalie Le Bastard3, Jean-Jacques Martin1, Johan Goeman4, Peter Paul De Deyn5, Sebastiaan Engelborghs6.   

Abstract

Hypothesizing that non-significant cerebrovascular lesions on structural brain imaging lead to overdiagnosis of a vascular etiology of dementia as compared to autopsy-confirmed diagnosis, we set up a study including 71 patients with autopsy-confirmed diagnoses. Forty-two patients in the population (59%) appeared to have definite Alzheimer's disease (AD), whereas 29 (41%) had a non-AD dementia form. The panel clinically diagnosed possible or probable vascular dementia (VaD) in 27 (38%) patients, whereas only five (19%) patients (p = 0.017) had an autopsy-confirmed diagnosis of VaD. Patients with vascular lesions on structural brain imaging were often misdiagnosed as possible or probable VaD as compared to autopsy-confirmed diagnosis.

Entities:  

Keywords:  Alzheimer's disease; brain imaging; dementia; differential dementia diagnosis; magnetic resonance imaging; vascular dementia

Mesh:

Year:  2015        PMID: 25633672     DOI: 10.3233/JAD-142103

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Mental speed is associated with the shape irregularity of white matter MRI hyperintensity load.

Authors:  Catharina Lange; Per Suppa; Anja Mäurer; Kerstin Ritter; Uwe Pietrzyk; Elisabeth Steinhagen-Thiessen; Jochen B Fiebach; Lothar Spies; Ralph Buchert
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

2.  Dementia: Cerebrospinal fluid biomarkers in dementias.

Authors:  Peter Paul De Deyn
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 3.  Alzheimer's disease CSF biomarkers: clinical indications and rational use.

Authors:  Ellis Niemantsverdriet; Sara Valckx; Maria Bjerke; Sebastiaan Engelborghs
Journal:  Acta Neurol Belg       Date:  2017-07-27       Impact factor: 2.396

Review 4.  Physical Activity: A Viable Way to Reduce the Risks of Mild Cognitive Impairment, Alzheimer's Disease, and Vascular Dementia in Older Adults.

Authors:  Patrick J Gallaway; Hiroji Miyake; Maciej S Buchowski; Mieko Shimada; Yutaka Yoshitake; Angela S Kim; Nobuko Hongu
Journal:  Brain Sci       Date:  2017-02-20

Review 5.  Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.

Authors:  Maria Bjerke; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.

Authors:  Mary O'Keeffe; Alexandra Barratt; Christopher Maher; Joshua Zadro; Alice Fabbri; Mark Jones; Ray Moynihan
Journal:  BMJ Open       Date:  2019-08-24       Impact factor: 2.692

Review 7.  Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.

Authors:  Qingwei Ruan; Grazia D'Onofrio; Daniele Sancarlo; Zhijun Bao; Antonio Greco; Zhuowei Yu
Journal:  BMC Geriatr       Date:  2016-05-16       Impact factor: 3.921

8.  Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.

Authors:  Ellis Niemantsverdriet; Bart F E Feyen; Nathalie Le Bastard; Jean-Jacques Martin; Johan Goeman; Peter Paul De Deyn; Maria Bjerke; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.